These medications are used for the treatment of a Cardiovascular Risk Factor Medication atenolol Mechanism of Action Selective

1-receptor blocker Cardiovascular Risk Reduction secondary prevention of cardic death Possible regular dose 50 mg

orlistat aspirin enalapril

Inhibits gastric and pancreatic lipases, reducing fat absorption inhbits cyclooxygenase activity thus inhibiting thromboxane and prostacyclin production angiotensin converting enzyme inhibitor angiotensin converting enzyme inhibitor decreases hepatic glucose production and intestinal glucose absorption; increases insulin sensitivity improvement in insulin secretion from the functioning beta cells of the pancreas selectively binds to 42 nicotinic acetylcholine receptors (nAChRs)in the mesolimbic system

reduced hypertension and stroke risk Prevention of thrombus formation in atherosclerotic vessels decrease urinary protein excretion thus reducing progression of renal disease secondary prevention of stroke

120 mg 100 mg 10 mg

perindopril

5 mg

metformin

prevention of acute mayocardial infarction

500 mg

gliclazide

prevention of peripheral limb ischaemia

80 mg

varenicline tartrate

prevention of atheroma formation

1 mg

d for the treatment of a Cardiovascular Risk Factor